amlexanox has been researched along with cromolyn in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Hou, T; Li, J; Liang, X; Qu, L; Shi, L; Wang, J; Wang, P; Wei, L; Zhang, X; Zhao, Y | 1 |
| Kashihara, M; Mizuguchi, M; Yokoyama, T | 1 |
2 other study(ies) available for amlexanox and cromolyn
| Article | Year |
|---|---|
Discovery of 2H-Chromen-2-one Derivatives as G Protein-Coupled Receptor-35 Agonists.
Topics: Benzopyrans; Carbon-13 Magnetic Resonance Spectroscopy; HT29 Cells; Humans; Mass Spectrometry; Proton Magnetic Resonance Spectroscopy; Receptors, G-Protein-Coupled | 2017 |
Repositioning of the Anthelmintic Drugs Bithionol and Triclabendazole as Transthyretin Amyloidogenesis Inhibitors.
Topics: Amyloid Neuropathies, Familial; Anthelmintics; Bithionol; Crystallography, X-Ray; Drug Repositioning; Humans; Prealbumin; Thermodynamics; Triclabendazole | 2021 |